Jennifer Renee Rider, ScD, MPH

Assistant Professor, Epidemiology
Jennifer Rider
(617) 358-3991rider@bu.edu

Biography

My primary research interests are in prostate cancer epidemiology and the identification of patient and tumor characteristics that could reduce overdiagnosis and overtreatment. Collaborating with research pathologists, urologists, medical oncologists, molecular biologists, immunologists, virologists, and bioinformaticists, I have utilized data from a large Swedish population-based studies (CaPS and PCBaSe) and a Swedish randomized trial (SPCG-4), Swedish clinical cohorts, the Physicians’ Health Study, and the Health Professionals Follow-up Study. I am also involved in ongoing studies of HPV infection in penile carcinoma and am pursuing projects that investigate malignancies in HIV-infected populations.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University

Education

  • Harvard School of Public Health, ScD
  • University of Massachusetts Amherst, MPH
  • University of Wisconsin Madison, BS

Classes Taught

  • SPHEP752
  • SPHEP813
  • SPHEP911
  • SPHEP912
  • SPHPH780

Publications

  • Published on 11/26/2019

    Bernard B, Burnett C, Sweeney CJ, Rider JR, Sridhar SS. Impact of age at diagnosis of de novo metastatic prostate cancer on survival. Cancer. 2019 Nov 26. PMID: 31769876.

    Read at: PubMed
  • Published on 11/21/2019

    Allott EH, Ebot EM, Stopsack KH, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Ahearn TU, Gerke TA, Downer MK, Rider JR, Freedland SJ, Lotan TL, Kantoff PW, Platz EA, Loda M, Stampfer MJ, Giovannucci E, Sweeney CJ, Finn SP, Mucci LA. Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer. Clin Cancer Res. 2019 Nov 21. PMID: 31754047.

    Read at: PubMed
  • Published on 8/29/2019

    Rider JR, Trinquart L. Observational Studies Have a Critical Role to Play in Cancer Comparative Effectiveness Research. J Clin Oncol. 2019 Oct 10; 37(29):2695-2696. PMID: 31465256.

    Read at: PubMed
  • Published on 7/16/2019

    Lajous M, Cooperberg MR, Rider J, Manzanilla-García HA, Gabilondo-Navarro FB, Rodríguez-Covarrubias FT, López-Ridaura R, Torres-Sánchez LE, Mohar A. Prostate cancer screening in low- and middle-income countries: the Mexican case. Salud Publica Mex. 2019 Jul-Aug; 61(4):542-544. PMID: 31314214.

    Read at: PubMed
  • Published on 7/1/2019

    Kantor ED, Haneuse S, Valdimarsdóttir UA, Williams DR, Signorello LB, Rider JR. Socioenvironmental adversity and risk of prostate cancer in non-Hispanic black and white men. Cancer Causes Control. 2019 Sep; 30(9):997-1007. PMID: 31264140.

    Read at: PubMed
  • Published on 4/26/2019

    Trinquart L, Bill-Axelson A, Rider JR. Restricted Mean Survival Times to Improve Communication of Evidence from Cancer Randomized Trials and Observational Studies. Eur Urol. 2019 Aug; 76(2):137-139. PMID: 31031048.

    Read at: PubMed
  • Published on 12/31/2018

    Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. 2018 12 31; 39(12):1431-1437. PMID: 30165429.

    Read at: PubMed
  • Published on 10/4/2018

    Vicier C, Werner L, Chipman J, Harshman LC, Patil DH, Fichorova RN, Rider JR, Sanda MG, Mucci LA, Sweeney CJ. Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer. Clin Genitourin Cancer. 2019 Feb; 17(1):32-37. PMID: 30348512.

    Read at: PubMed
  • Published on 9/18/2018

    Johnson-Obaseki S, Caulley L, Corsten M, Liu G, Dimitroulakos J, Goldstein D, Irish J, Rider J. C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2019 03; 160(3):494-501. PMID: 30226795.

    Read at: PubMed
  • Published on 8/23/2018

    Davidsson S, Carlsson J, Giunchi F, Harlow A, Kirrander P, Rider J, Fiorentino M, Andrén O. PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes. Eur Urol Oncol. 2019 Mar; 2(2):214-221. PMID: 31017099.

    Read at: PubMed

View 87 more publications:View full profile at BUMC

News & In the Media